Biostock Investor Meeting Interview With Combigene September 2023

Biostock Investor Meeting Interview With Combigene September 2023 Biostock interviews peter ekolind, ceo of combigene at biostock investor meeting september 2023.0:00 introduction0:20 what does combigene do?0:50 pipeline2:1. September 26, 2023 see the interview with ceo peter ekolind at biostock investor meeting here: biostock investor meeting | interview with combigene | september 2023 –.

Biostock Investor Meeting September 2023 Combigene Youtube Watch this year’s autumn edition of biostock investor meeting where representatives from a number of life science companies present their business case.the f. Vd peter ekolind presenterar combigene vid biostock investor meeting i september 20230:00 introduktion1:00 combigene i korthet1:43 genterapi2:09 combigenes p. Combigene – peter ekolind, ceo annexin pharmaceuticals – anders haegerstrand, ceo aptahem – mikael lindstam, ceo (in swedish) dicot – elin trampe, ceo (in swedish) synartro – mia brundin, ceo. the content of biostock’s news and analyses is independent but the work of biostock is to a certain degree financed by life science companies. At biostock investor meeting on september 20, 2023, we had the opportunity to pick the brain of one of sweden’s most savvy life science investors, live on stage! with decades of industry experience and a track record of starting, building and exiting successful ventures like recipharm, thomas eldered is also the co founder and chairman of.

Biostock Investor Meeting September 2023 Biostock Combigene – peter ekolind, ceo annexin pharmaceuticals – anders haegerstrand, ceo aptahem – mikael lindstam, ceo (in swedish) dicot – elin trampe, ceo (in swedish) synartro – mia brundin, ceo. the content of biostock’s news and analyses is independent but the work of biostock is to a certain degree financed by life science companies. At biostock investor meeting on september 20, 2023, we had the opportunity to pick the brain of one of sweden’s most savvy life science investors, live on stage! with decades of industry experience and a track record of starting, building and exiting successful ventures like recipharm, thomas eldered is also the co founder and chairman of. 4 september, 2023. jan nilsson, ceo of gene therapy company combigene since 2016, has left his post and last friday peter ekolind, former coo, took over as the new ceo. ekolind, previously ceo of getinge sweden, tells biostock that combigene is in a dynamic and exciting phase with the potential to achieve several milestones in the future. Biostock interviews peter ekolind, ceo of combigene at biostock investor meeting. see the interview here: lnkd.in djkkwgsy.